Based on phenotypic characteristics, this population of lymphocytes accounts for 5–10% of all CD4+ T cells in the peripheral circulation of healthy individuals (e.g., Wolf et al, 2003), but in patients with cancer, peripheral mononuclear cells (PBMC) may contain up to 25–30% of Treg (Woo et al, 2002). Here, CD4 is linked to cancer.